ENTvantage Diagnostics

Entvantage Diagnostics has developed Sinu-Test®, the first rapid, in-office test for bacterial sinusitis detection. The Sinu-Test Bacterial Sinusitis Test Kit includes a proprietary collection device, bacterial assay kit, and optical reader device that provides accurate, rapid, in-office diagnostic test results for the determination of bacterial sinusitis. The first-of-its-kind, FDA Class II DeNovo Diagnostic test kit, with issued patents in the U.S., EU, Australia, and Japan, provides primary care and ENT physicians with a simple and accurate point-of-care test for sinusitis that takes 20 minutes to achieve results and allows healthcare providers to determine the 10% of patients that have bacterial sinusitis and can benefit from antibiotics from the 90% that have viral sinusitis where antibiotics are ineffective.

The Sinu-Test diagnostics test kit will help providers reduce the number of unnecessary antibiotic prescriptions, increase revenue to the clinic using established CPT reimbursement codes that pay $55 per test, and reduce the overall treatment costs for these illnesses from $400 to $125 with the use of the Sinu-Test. Clinical testing is underway in the U.S.